Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The Emergency Lawsuit and Its Rapid Collapse
Discovery Behavioral Health, a major operator of more than 130 behavioral health treatment programs nationwide, mounted an emergency legal challenge in New York Supreme Court on December 15, 2025, seeking to block what it characterized as an unlawful lender takeover of its business. The case, Discovery Behavioral Health, Inc. v. Capital One, National Association, et al., No. 656437/2025, was filed in the Commercial Division and assigned to the New York County Supreme Court.¹
Represented by Goodwin Procter, Discovery alleged that Capital One and its unitranche lending partner, HPS Investment Partners, improperly declared defaults under a $280 million credit facility and then moved to seize voting control of the company. According to the complaint, lenders replaced Discovery’s board of directors on December 12, despite the company’s assertion that it remained in compliance with financial covenants and had not missed any loan payments. Discovery framed the lenders’ actions as a bad-faith effort to gain leverage over a healthcare provider during a period of operational restructuring.
The legal effort was short-lived. After a single hearing on December 16, the court declined to grant a temporary restraining order. While the judge indicated a willingness to restrict an immediate “fire sale” of Discovery’s assets, no broader relief was granted. Discovery withdrew its motions on December 21, effectively ending the case and clearing the path for Capital One and HPS to maintain control. Barring an undisclosed outside transaction, Discovery Behavioral Health has now been effectively repossessed by its lenders.
Inside the Alleged Default and Lender Takeover
Court filings show that Capital One and HPS determined Discovery to be in default based on how the company calculated its debt-to-earnings ratio in quarterly compliance reports. The dispute centers on a December 2024 change in accounting treatment for expenses tied to closed facilities. Discovery had excluded certain costs associated with shuttered programs, including ongoing rent and utilities, arguing that those expenses related to discontinued operations and distorted ongoing performance.
Capital One disagreed. According to the lenders, had Discovery continued using its prior methodology, it would have breached its maximum leverage ratio and triggered an event of default. That disagreement escalated into a formal notice of potential default in May 2025. By December, Capital One declared an actual default and exercised its rights to remove the board and install its own slate of directors, effectively taking operational control of the company.
Discovery’s complaint emphasized that it had not missed any debt service payments and that covenant calculations had been repeatedly amended and negotiated over time. It argued that the credit agreement was never intended to penalize operational cost-cutting that would strengthen long-term profitability. Nonetheless, the lenders prevailed in court, and Discovery’s challenge failed to halt the takeover.
For behavioral health executives, the episode underscores how covenant interpretation, not payment performance, can become the decisive trigger in lender enforcement actions. Atlantic Health Strategies has repeatedly advised provider organizations that leverage ratios and reporting definitions carry existential risk when capital structures tighten. This case illustrates how quickly lenders can move once defaults are asserted.
Facility Closures, Strategy Shifts, and Financial Stress
Discovery Behavioral Health’s financial challenges unfolded alongside a strategic pivot away from residential treatment toward outpatient care. Since 2023, the company shuttered dozens of facilities, including as many as 15 residential programs during an early phase of the transition. Former CEO John Peloquin publicly described the shift as a necessary realignment toward scalable, lower-cost outpatient models.
Despite the closures, Discovery continued to incur substantial legacy expenses tied to the closed facilities. Long-term leases, utilities, and related obligations remained on the books even as programs ceased operations. In its complaint, Discovery argued that these costs would decline significantly over the coming year and that excluding them from leverage calculations more accurately reflected the company’s forward-looking earnings capacity.
From a lender’s perspective, however, the closures signaled heightened risk. Dozens of closed sites, coupled with repeated covenant amendments, created a credit profile increasingly reliant on sponsor support and lender forbearance. When negotiations over further amendments broke down in fall 2025, Capital One moved decisively.
Atlantic Health Strategies routinely sees similar dynamics across the behavioral health sector. Platform providers pursuing outpatient transitions often underestimate how legacy real estate obligations and covenant rigidity can collide. Without proactive restructuring of credit agreements, strategic pivots can unintentionally accelerate lender enforcement rather than stabilize operations.
Credit Agreement Amendments and Failed Negotiations
Discovery entered into its debt agreements with Capital One and HPS in June 2021. Over the next several years, the parties executed multiple amendments that waived defaults and reset financial guardrails. These amendments reveal a pattern of ongoing financial strain masked by negotiated flexibility.
An August 2022 amendment increased one tranche of debt from $25 million to $30 million. A more consequential amendment in May 2024 waived several defaults, including violations of leverage ratios for the fourth quarter of 2023, late financial reporting, and failures to deliver required compliance certificates. The amendment also retroactively increased Discovery’s permitted debt-to-earnings ratio through the fourth quarter of 2024, ultimately setting the ratio at 6.63 to 1.
After the May 2025 notice of potential default, Discovery and Capital One explored yet another amendment. That proposal hinged on Webster Equity Partners, Discovery’s sponsor, selling the company’s outpatient division, Discovery Medical Services, and using the proceeds to stabilize the balance sheet. Draft documentation progressed into October.
On October 13, 2025, Capital One learned that the sale would not be consummated and that the amendment would not be executed. That collapse appears to have been the inflection point. Within weeks, lenders escalated from negotiation to enforcement, culminating in the December takeover.
For Atlantic Health Strategies clients, this sequence reinforces a core lesson. Amendment fatigue eventually erodes lender tolerance. When contingency transactions fail, lenders often act swiftly to preserve value, even if doing so destabilizes operations in the short term.
Implications for Behavioral Health Operators and Investors
The Discovery Behavioral Health case represents a sobering signal for the behavioral healthcare industry. Lenders are increasingly willing to assert control rights when covenant compliance becomes ambiguous, particularly in sponsor-backed platforms with complex capital stacks. The fact that Discovery continued making payments did not insulate it from enforcement once reporting disputes escalated.
The court’s refusal to block the takeover also highlights the limited protection available to operators once defaults are declared. Absent clear evidence of lender misconduct, courts are reluctant to interfere with contractual remedies. Discovery’s inability to secure even temporary relief illustrates how narrow the window can be for defensive litigation.
For operators, the lesson is not simply legal. It is operational. Financial reporting definitions, treatment of discontinued operations, and alignment with lender expectations must be managed with the same rigor as clinical compliance. Atlantic Health Strategies emphasizes that compliance risk now extends deeply into finance and governance.
For investors and sponsors, the case raises questions about exit planning and lender relations. Reliance on asset sales to cure defaults carries execution risk. When those transactions fail, sponsors may find themselves sidelined as lenders step in. The Discovery situation will likely influence how lenders structure future behavioral health deals, with tighter controls and fewer concessions.
References
-
Discovery Behavioral Health, Inc. v. Capital One, National Association, Index No. 656437/2025, New York Supreme Court, New York County. https://iapps.courts.state.ny.us
-
New York Supreme Court Commercial Division Overview. https://nycourts.gov/COURTS/comdiv
-
U.S. Department of Health and Human Services, Behavioral Health Market Trends and Consolidation. https://www.hhs.gov